This program is intended for physicians, pharmacists, registered nurses, and other healthcare professionals who care for persons with HIV.
The goal of this program is to improve learners’ knowledge and competence regarding the evolving field of HIV care including current best practices in HIV service delivery, the potential role of emerging ART options, and key concepts in HIV cure research.
Upon completion of this activity, participants should be able to:
Better engage with HIV cure research in ways that span from PWH counselling to clinical trial participation, through a robust understanding of key concepts and potential interventions
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:
Katharine J. Bar, MD
Associate Professor of Medicine
Director, Penn CFAR Virus and Reservoirs Core
University of Pennsylvania
Katharine J. Bar, MD: consultant/advisor/Speaker: AbbVie.
Jennifer Blanchette, PhD
Clinical Care Options
Colorado, United States
Jennifer Blanchette, PhD, has no relevant financial relationships to disclose.
Krista L. Dong, MD
Clinical Director, FRESH Cohort
Assistant Professor of Medicine
Massachusetts General Hospital
Harvard Medical School
Krista L. Dong, MD: researcher: Gilead.
Karine Dubé, DrPH, MPhil
UCSD School of Medicine
Division of Infectious Diseases and Global Public Health
San Diego, California
Karine Dubé, DrPH, MPhil: consultant/advisor/speaker: Gilead Sciences.
Basic Science, Vaccines & Cure Project Director
Treatment Action Group
New York, New York
Richard Jefferys has no relevant financial relationships to disclose.
Sharon R. Lewin, AO, FRACP, PhD, FAHMS
Melbourne Laureate Professor and Head
Department of Infectious Diseases
The University of Melbourne
Victorian Infectious Diseases Service
Royal Melbourne Hospital
Consultant Physician and Adjunct Professor Department of Infectious Diseases
Alfred Hospital and Monash University
Sharon R. Lewin, AO, FRACP, PhD, FAA, FAHMS: consultant/advisor/speaker: AbbVie, Efsam, Gilead, Immunocore, Merck, Vaxxinity, ViiV; safety monitoring committee: Gilead; researcher: Gilead, Merck.
4M Network of Mentor Mothers
London, United Kingdom
Angelina Namiba, has no financial relationships to disclose.
The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose.
Participation in this self-study activity should be completed in approximately 1 hour. To successfully complete this activity and receive credit, participants must follow these steps during the period from December 11, 2023, through December 10, 2024:
You must respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.
This program has been made available online.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Joint Accreditation Statement
In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
CCO designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1 contact hour.
Continuing Pharmacy Education
CCO designates this continuing education activity for 1 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number - JA4008176-0000-23-316-H02-P
Type of Activity: Knowledge
Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.